These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 145840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute challenge with apomorphine in Huntington's disease: a double-blind study.
    Albanese A, Cassetta E, Carretta D, Bentivoglio AR, Tonali P.
    Clin Neuropharmacol; 1995 Oct; 18(5):427-34. PubMed ID: 8665556
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
    Donatelli L.
    Clin Ter; 1977 Jun 15; 81(5):395-416. PubMed ID: 18317
    [No Abstract] [Full Text] [Related]

  • 7. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S, De la Vega C, Garelis E, Sourkes TL.
    Psychiatr Neurol Neurochir; 1973 Jun 15; 76(2):113-7. PubMed ID: 4267059
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.
    Corsini GU, Zompo MD, Cianchetti C, Mangoni A.
    Psychopharmacologia; 1976 May 28; 47(2):169-73. PubMed ID: 1273213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of DA agonist in Huntington disease hyperkinesia.
    Caraceni TA, Girotti F, Giovannini P, Pederzoli M, Parati EA.
    Ital J Neurol Sci; 1980 Jun 28; 1(3):155-61. PubMed ID: 6210644
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic experience with transdihydrolisuride in Huntington's disease.
    Bassi S, Albizzati MG, Corsini GU, Frattola L, Piolti R, Suchy I, Trabucchi M.
    Neurology; 1986 Jul 28; 36(7):984-6. PubMed ID: 2940475
    [Abstract] [Full Text] [Related]

  • 18. Effects of dopamine agonists and antagonists in Tourette's disease.
    Feinberg M, Carroll BJ.
    Arch Gen Psychiatry; 1979 Aug 28; 36(9):979-85. PubMed ID: 380492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ergot alkaloids and cyclic nucleotides in the CNS.
    Trabucchi M, Hofmann M, Montefusco O, Spano PF.
    Pharmacology; 1978 Aug 28; 16 Suppl 1():150-55. PubMed ID: 205889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.